Atlas Trials

Intellia Therapeutics

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Intellia Therapeutics

RecordFirmDate
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) (NCT06634420)Intellia Therapeutics2025-01-15
A Phase 3 Study of NTLA-2001 in ATTRv-PN (NCT06672237)Intellia Therapeutics2024-11-22
NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (NCT06622668)Intellia Therapeutics2024-11-20
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002 (NCT06262399)Intellia Therapeutics2024-04-12
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) (NCT06128629)Intellia Therapeutics2023-12-13
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 (NCT05697861)Intellia Therapeutics2023-07-10
Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia (NCT05066165)Intellia Therapeutics2021-12-17
NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NCT05120830)Intellia Therapeutics2021-12-10
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) (NCT04601051)Intellia Therapeutics2020-11-05

Track Intellia Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.